All In MedTech

FDA Clearance Tracker · P130008-S092

SleepSync Programmer

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jun 27, 2023 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Jun 27, 2023

Approved

Time to decision

225 days

Received Nov 14, 2022. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P130008-S092
Device name
SleepSync Programmer
Applicant location
Maple Grove, MN
Received
Nov 14, 2022
Decided
Jun 27, 2023
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P130008

Device type

Device class
Class III

Every decision under product code MNQ

FDA's approval statement

As written in FDA's record.

Approval for the updated SleepSync Programmer (Model 2740) which consists of the Inspire Programming Software Application (Model 2740S) that can be installed on customer owned devices and paired with the Inspire Programmer Cable (Model 2740C).

Source documents

Other decisions for Inspire Medical Systems

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

2 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.